NORTH BILLERICA, Mass.--(BUSINESS WIRE)-- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc., and EXINI ...
Recent advancements in deep learning have significantly transformed the field of nuclear medicine, specifically in the detection and analysis of bone metastases via scintigraphy. By leveraging ...
A biopsy is the only test that can confirm a cancer diagnosis. However, before doctors conduct a biopsy, they may take a person’s medical history, perform a physical exam, and order various imaging ...
The influence of physician densities and patient characteristics on the decision to treat prostate cancer patients with varying clinical benefit. Background: The risk of prematurely discontinuing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results